A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. Verma R, Silva KED, Rockwood N, Wasmann RE, et al. Am J Respir Crit Care Med 2024 Mar 5. doi: 10.1164/rccm.202309-1583.

Read + Share

Amedeo Smart

Independent Medical Education

Verma R, Silva KED, Rockwood N, Wasmann RE, et al. A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. Am J Respir Crit Care Med 2024 Mar 5. doi: 10.1164/rccm.202309-1583.
PMID: 38647526